Literature DB >> 8616910

Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing.

L B Lan1, S Ayesh, E Lyubimov, I Pashinsky, W D Stein.   

Abstract

We determined the kinetic parameters that describe the effect of 20 different modulators of the multidrug resistance pump on the reversal of cytotoxin accumulation in a resistant strain of P388 leukemia cells (P388/ADR), and on the reversal of cell killing for these cells. When measured by a direct comparison of the amplitude of the pertinent protocol (accumulation or cell killing), the Ki for reversal of accumulation was generally some four or five times larger than that for reduction of cytotoxicity. We showed that this was only an apparent discrepancy, since a full theoretical analysis of the two protocols allowed the intrinsic Ki to be obtained for the two procedures and these computed Ki values were then almost identical. We found that for six of the modulators studied (namely, cyclosporin A, quinidine, dipyridamole, propafenone, mefloquine, tamoxifen) the extent of pump reversal should be better than 90% at tolerated plasma levels culled from the literature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616910     DOI: 10.1007/s002800050468

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  9 in total

1.  In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity.

Authors:  Y Chen; S M Simon
Journal:  J Cell Biol       Date:  2000-03-06       Impact factor: 10.539

2.  Is alpha-pinene a substrate for permeability-glycoprotein in wood rats?

Authors:  Adam K Green; Shannon L Haley; David M Barnes; M Denise Dearing; William H Karasov
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

3.  Automated synthesis of 18F analogue of paclitaxel (PAC): [18F]Paclitaxel (FPAC).

Authors:  Joseph D Kalen; Jerry I Hirsch; Karen A Kurdziel; William C Eckelman; Dale O Kiesewetter
Journal:  Appl Radiat Isot       Date:  2006-12-11       Impact factor: 1.513

4.  A new method to measure intestinal activity of P-glycoprotein in avian and mammalian species.

Authors:  Adam K Green; David M Barnes; William H Karasov
Journal:  J Comp Physiol B       Date:  2004-11-25       Impact factor: 2.200

5.  In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Christophe Rousselle; Marcel Debray; Jean-Michel Scherrmann
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

6.  Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice.

Authors:  Sylvie Barraud de Lagerie; Emmanuelle Comets; Céline Gautrand; Christine Fernandez; Daniel Auchere; Eric Singlas; France Mentre; François Gimenez
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

7.  Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative.

Authors:  María L González; D Mariano A Vera; Jerónimo Laiolo; Mariana B Joray; Mariana Maccioni; Sara M Palacios; Gabriela Molina; Priscila A Lanza; Samanta Gancedo; Vivian Rumjanek; María C Carpinella
Journal:  Front Pharmacol       Date:  2017-04-25       Impact factor: 5.810

8.  Bromocriptine reverses P-glycoprotein-mediated multidrug resistance in tumor cells.

Authors:  Nobuaki Shiraki; Keiko Okamura; Jin Tokunaga; Takafumi Ohmura; Kazuto Yasuda; Takeo Kawaguchi; Akinobu Hamada; Masahiro Nakano
Journal:  Jpn J Cancer Res       Date:  2002-02

9.  The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation.

Authors:  S M D K Ganga Senarathna; Madhu Page-Sharp; Andrew Crowe
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.